Table 1.
Study | Setting | N | Lipase >3x | Outcome |
Wang et al. (2) | Single center, China | 62 | 0 | Potential mild pancreatic injury in COVID; none had clinically significant pancreatic involvement |
McNabb-Baltar et al. (3) | 6 centers, USA | 71 | 2 | No impact of hyperlipasemia on clinical parameters; none had clinically significant pancreatic involvement |
Barlass et al. (1) | Single center, USA | 83 | 14 | Hyperlipasemia associated with poor prognosis; none had clinically significant pancreatic involvement |